Literature DB >> 19106098

Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation.

Sarah B Scruggs1, Aaron C Hinken, Ariyaporn Thawornkaiwong, Jeffrey Robbins, Lori A Walker, Pieter P de Tombe, David L Geenen, Peter M Buttrick, R John Solaro.   

Abstract

There is little direct evidence on the role of myosin regulatory light chain phosphorylation in ejecting hearts. In studies reported here we determined the effects of regulatory light chain (RLC) phosphorylation on in situ cardiac systolic mechanics and in vitro myofibrillar mechanics. We compared data obtained from control nontransgenic mice (NTG) with a transgenic mouse model expressing a cardiac specific nonphosphorylatable RLC (TG-RLC(P-). We also determined whether the depression in RLC phosphorylation affected phosphorylation of other sarcomeric proteins. TG-RLC(P-) demonstrated decreases in base-line load-independent measures of contractility and power and an increase in ejection duration together with a depression in phosphorylation of myosin-binding protein-C (MyBP-C) and troponin I (TnI). Although TG-RLC(P-) displayed a significantly reduced response to beta(1)-adrenergic stimulation, MyBP-C and TnI were phosphorylated to a similar level in TG-RLC(P-) and NTG, suggesting cAMP-dependent protein kinase signaling to these proteins was not disrupted. A major finding was that NTG controls were significantly phosphorylated at RLC serine 15 following beta(1)-adrenergic stimulation, a mechanism prevented in TG-RLC(P-), thus providing a biochemical difference in beta(1)-adrenergic responsiveness at the level of the sarcomere. Our measurements of Ca(2+) tension and Ca(2+)-ATPase rate relations in detergent-extracted fiber bundles from LV trabeculae demonstrated a relative decrease in maximum Ca(2+)-activated tension and tension cost in TG-RLC(P-) fibers, with no change in Ca(2+) sensitivity. Our data indicate that RLC phosphorylation is critical for normal ejection and response to beta(1)-adrenergic stimulation. Our data also indicate that the lack of RLC phosphorylation promotes compensatory changes in MyBP-C and TnI phosphorylation, which when normalized do not restore function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19106098      PMCID: PMC2643522          DOI: 10.1074/jbc.M807414200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation.

Authors:  J S Davis; S Hassanzadeh; S Winitsky; H Lin; C Satorius; R Vemuri; A H Aletras; H Wen; N D Epstein
Journal:  Cell       Date:  2001-11-30       Impact factor: 41.582

2.  Kinetic effects of myosin regulatory light chain phosphorylation on skeletal muscle contraction.

Authors:  Julien S Davis; Colleen L Satorius; Neal D Epstein
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

3.  Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice.

Authors:  X Wang; H Osinska; R Klevitsky; A M Gerdes; M Nieman; J Lorenz; T Hewett; J Robbins
Journal:  Circ Res       Date:  2001-07-06       Impact factor: 17.367

4.  Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2.

Authors:  G Kunst; K R Kress; M Gruen; D Uttenweiler; M Gautel; R H Fink
Journal:  Circ Res       Date:  2000 Jan 7-21       Impact factor: 17.367

5.  Effects of calcium, inorganic phosphate, and pH on isometric force in single skinned cardiomyocytes from donor and failing human hearts.

Authors:  J van Der Velden; L J Klein; R Zaremba; N M Boontje; M A Huybregts; W Stooker; L Eijsman; J W de Jong; C A Visser; F C Visser; G J Stienen
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

6.  Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffening.

Authors:  Bradley M Palmer; Dimitrios Georgakopoulos; Paul M Janssen; Yuan Wang; Norman R Alpert; Diego F Belardi; Samantha P Harris; Richard L Moss; Patrick G Burgon; Christine E Seidman; J G Seidman; David W Maughan; David A Kass
Journal:  Circ Res       Date:  2004-04-01       Impact factor: 17.367

7.  Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium.

Authors:  YeQing Pi; Dahua Zhang; Kara R Kemnitz; Hao Wang; Jeffery W Walker
Journal:  J Physiol       Date:  2003-08-15       Impact factor: 5.182

8.  The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is enhanced in failing human hearts.

Authors:  J van der Velden; Z Papp; N M Boontje; R Zaremba; J W de Jong; P M L Janssen; G Hasenfuss; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-02       Impact factor: 10.787

9.  Phosphoproteome analysis of cardiomyocytes subjected to beta-adrenergic stimulation: identification and characterization of a cardiac heat shock protein p20.

Authors:  Guoxiang Chu; Gregory F Egnaczyk; Wen Zhao; Su-Hyun Jo; Guo-Chang Fan; John E Maggio; Rui-Ping Xiao; Evangelia G Kranias
Journal:  Circ Res       Date:  2003-11-13       Impact factor: 17.367

10.  Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins.

Authors:  J van der Velden; Z Papp; R Zaremba; N M Boontje; J W de Jong; V J Owen; P B J Burton; P Goldmann; K Jaquet; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-01       Impact factor: 10.787

View more
  75 in total

1.  Why is it important to analyze the cardiac sarcomere subproteome?

Authors:  R John Solaro; Chad M Warren; Sarah B Scruggs
Journal:  Expert Rev Proteomics       Date:  2010-06       Impact factor: 3.940

Review 2.  Structure, interactions and function of the N-terminus of cardiac myosin binding protein C (MyBP-C): who does what, with what, and to whom?

Authors:  Mark Pfuhl; Mathias Gautel
Journal:  J Muscle Res Cell Motil       Date:  2012-04-20       Impact factor: 2.698

3.  A novel, in-solution separation of endogenous cardiac sarcomeric proteins and identification of distinct charged variants of regulatory light chain.

Authors:  Sarah B Scruggs; Rick Reisdorph; Mike L Armstrong; Chad M Warren; Nichole Reisdorph; R John Solaro; Peter M Buttrick
Journal:  Mol Cell Proteomics       Date:  2010-05-05       Impact factor: 5.911

Review 4.  Multi-scale computational models of familial hypertrophic cardiomyopathy: genotype to phenotype.

Authors:  Stuart G Campbell; Andrew D McCulloch
Journal:  J R Soc Interface       Date:  2011-08-10       Impact factor: 4.118

5.  Cardiac myosin is a substrate for zipper-interacting protein kinase (ZIPK).

Authors:  Audrey N Chang; Guohua Chen; Robert D Gerard; Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

Review 6.  Pseudophosphorylation of cardiac myosin regulatory light chain: a promising new tool for treatment of cardiomyopathy.

Authors:  Sunil Yadav; Danuta Szczesna-Cordary
Journal:  Biophys Rev       Date:  2017-01-25

Review 7.  Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations.

Authors:  Wenrui Huang; Danuta Szczesna-Cordary
Journal:  J Muscle Res Cell Motil       Date:  2015-09-18       Impact factor: 2.698

Review 8.  Integration of troponin I phosphorylation with cardiac regulatory networks.

Authors:  R John Solaro; Marcus Henze; Tomoyoshi Kobayashi
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

Review 9.  Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains.

Authors:  Sunil Yadav; Yoel H Sitbon; Katarzyna Kazmierczak; Danuta Szczesna-Cordary
Journal:  Pflugers Arch       Date:  2019-01-31       Impact factor: 3.657

Review 10.  Phosphorylation and function of cardiac myosin binding protein-C in health and disease.

Authors:  David Barefield; Sakthivel Sadayappan
Journal:  J Mol Cell Cardiol       Date:  2009-12-03       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.